Advancing a US Single-Payer Model for Cell and Gene Therapy.
Sign Up to like & getrecommendations! Published in 2025 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2025.5058
Abstract: This Viewpoint discusses the status of regulatory approval and reimbursement for cell and gene therapies in Europe and the US. read more here.
Keywords: advancing single; single payer; cell gene; payer model ... See more keywords